FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients and carers should be made aware that behavioural symptoms of impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists including MIRAPEXIN.
Slovenian: Bolnikom in negovalcem je treba povedati, da se lahko pri bolnikih, ki se zdravijo z dopaminskimi agonisti, tudi z zdravilom MIRAPEXIN, pojavijo vedenjski simptomi motenj nadzora impulzov, kot so patološko hazardiranje, povečan libido, hiperseksualnost, kompulzivno trošenje denarja ali nakupovanje, prenajedanje in kompulzivno uživanje hrane.
English: Co-administration of antipsychotic medicinal products with pramipexole should be avoided (see section 4.5).
Slovenian: Sočasni uporabi antipsihotičnih zdravil in pramipeksola se je treba izogibati (glejte poglavje 4.5).
English: If you have kidney disease, your doctor may advise you to take the usual starting dose of 0.26 mg prolonged-release tablets only every other day for the first week.
Slovenian: Če imate ledvično bolezen, vam bo zdravnik lahko svetoval, naj jemljete prvi teden običajni začetni odmerek tablet s podaljšanim sproščanjem po 0,26 mg vsak drugi dan. Nato bo lahko povečal pogostnost jemanja na eno tableto s podaljšanim sproščanjem po 0,26 mg na dan.
English: How to take MIRAPEXIN
Slovenian: Kako jemati zdravilo MIRAPEXIN
English: If you are taking levodopa, the dose of levodopa is recommended to be reduced when you start treatment with MIRAPEXIN.
Slovenian: Če jemljete levodopo, je njen odmerek na začetku zdravljenja z zdravilom MIRAPEXIN priporočljivo zmanjšati.
English: It is recommended that the dose of levodopa is reduced during both the dose escalation and the maintenance treatment with MIRAPEXIN, depending on reactions in individual patients (see section
Slovenian: Priporočljivo je, da se glede na reakcije posameznih bolnikov odmerjanje levodope zmanjša tako med povečevanjem odmerka zdravila MIRAPEXIN kot med vzdrževalnim zdravljenjem z zdravilom MIRAPEXIN (glejte poglavje
English: Parkinson's disease, most common adverse reactions The most commonly (≥ 5%) reported adverse drug reactions in patients with Parkinson's disease more frequent with pramipexole treatment than with placebo were nausea, dyskinesia, hypotension, dizziness, somnolence, insomnia, constipation, hallucination, headache and fatigue.
Slovenian: Parkinsonova bolezen, najpogostnejši neželeni učinki Neželeni učinki, o katerih so najpogosteje poročali ( 5%) pri bolnikih s Parkinsonovo boleznijo in so bili med zdravljenjem s pramipeksolom pogostnejši kot med jemanjem placeba, so bili slabost, diskinezija, hipotenzija, omotica, zaspanost, nespečnost, zaprtost, halucinacije, glavobol in utrujenost.
English: A precise frequency estimation is not possible as the side effect did not occur in a clinical trial database of 1,395 patients with Restless Legs Syndrome treated with pramipexole
Slovenian: Njegove pogostnosti ni možno natančno oceniti, ker se ni pojavil v zbirki podatkov iz kliničnih preskušanj, v kateri so podatki o 1.395 bolnikih s sindromom nemirnih nog, ki so se zdravili z pramipeksolom.
English: What MIRAPEXIN looks like and contents of the pack MIRAPEXIN 0.26 mg and 0.52 mg prolonged-release tablets are white to off-white, of round shape, and have bevelled edges.
Slovenian: Izgled zdravila MIRAPEXIN in vsebina pakiranja MIRAPEXIN 0,26 mg in 0,52 mg tablete s podaljšanim sproščanjem so bele do skoraj bele, okrogle in imajo zaobljen rob.
English: The once daily administration of MIRAPEXIN prolonged-release tablets causes less frequent fluctuations in the pramipexole plasma concentration over 24 hours compared to the three times daily administration of pramipexole immediate release tablets.
Slovenian: Pri jemanju MIRAPEXIN tablet s podaljšanim sproščanjem enkrat na dan prihaja v primerjavi z jemanjem tablet pramipeksola s takojšnjim sproščanjem trikrat na dan manj pogosto do nihanja 24-urne koncentracije pramipeksola v plazmi.
English: Store in the original package to protect the tablets from light.
Slovenian: Shranjujte v originalni ovojnini za zagotovitev zaščite tablet pred svetlobo.
English: EXPIRY DATE EXP {MM/YYYY}
Slovenian: DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA EXP {MM/LLLL}
English: In advanced Parkinson's disease, pramipexole doses higher than 1.1 mg of base (1.5 mg of salt) per day can be useful in patients where a reduction of the levodopa therapy is intended.
Slovenian: Odmerki pramipeksola, večji od 1,1 mg baze (1,5 mg soli) na dan, so lahko koristni pri bolnikih z napredovalo Parkinsonovo boleznijo, pri katerih je predvideno zmanjšanje zdravljenja z levodopo.
English: Common: - Changes in sleep pattern, such as sleeplessness (insomnia) and sleepiness - Tiredness (fatigue) - Headache - Abnormal dreams - Constipation - Dizziness - Vomiting (being sick)
Slovenian: Pogosti: - sprememba vzorca spanja, na primer nespečnost (insomnia) in zaspanost; - utrujenost, - glavobol, - nenormalne sanje, - zaprtje, - omotica, - bruhanje (slabost).
English: MIRAPEXIN 0.18 mg tablets and MIRAPEXIN 0.35 mg tablets are white, of oval shape, and flat.
Slovenian: MIRAPEXIN 0,18 mg tablete in MIRAPEXIN 0,35 mg tablete so bele, ovalne in ploščate.
English: If you have moderate kidney disease, the usual starting dose is 1 tablet MIRAPEXIN 0.088 mg twice a day.
Slovenian: Če imate zmerno hudo ledvično bolezen, bo vaš začetni odmerek 1 tableta zdravila MIRAPEXIN po 0,088 mg 2-krat na dan.
English: What MIRAPEXIN looks like and contents of the pack MIRAPEXIN 0.088 mg tablets are white, of round shape, flat, and without scoring.
Slovenian: Izgled zdravila MIRAPEXIN in vsebina pakiranja MIRAPEXIN 0,088 mg tablete so bele, okrogle, ploščate in brez zareze.
English: Parkinson's disease and are also taking levodopa, you might develop dyskinesia during the up titration of MIRAPEXIN.
Slovenian: Parkinsonovo bolezen in sočasno jemljete levodopo, se lahko pri vas med povečevanjem odmerkov zdravila MIRAPEXIN razvije diskinezija.
English: Do not chew, divide or crush the prolongedrelease tablets.
Slovenian: Tablet s podaljšanim sproščanjem ne žvečite niti delite ali drobite.
English: If renal function declines during maintenance therapy the MIRAPEXIN daily dose should be reduced by the same percentage as the decline in creatinine clearance, i.e. if creatinine clearance declines by 30%, then the MIRAPEXIN daily dose should be reduced by 30%.
Slovenian: Če ledvična funkcija med vzdrževalnim zdravljenjem upade, naj bi dnevni odmerek zdravila MIRAPEXIN zmanjšali za enak odstotek, kot je upadel očistek kreatinina.
English: Uncommon: - Paranoia (e.g. excessive fear for one's own well-being) - Delusion - Excessive daytime sleepiness and suddenly falling asleep - Amnesia (memory disturbance) - Hyperkinesia (increased movements and inability to keep still) - Weight increase - Allergic reactions (e.g. rash, itching, hypersensitivity) - Fainting - Cardiac failure (heart problems which can cause shortness of breath or ankle swelling)* - Inappropriate antidiuretic hormone secretion* - Restlessness - Dyspnoea (difficulties to breathe) - Hiccups - Pneumonia (infection of the lungs) - Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
Slovenian: Občasni: - paranoja (na primer prevelik strah za lastno dobrobit), - blodnje, - prevelika zaspanost podnevi in nenaden spanec, - amnezija (moten spomin), - hiperkinezija (čezmerni gibi in nezmožnost mirovanja), - zvečanje telesne mase, - alergijske reakcije (npr. izpuščaj, srbenje, preobčutljivost), - omedlevica, - srčno popuščanje (srčne motnje, ki lahko povzročijo težave z dihanjem in otekanje gležnjev)*, - nemir, - dispneja (težave pri dihanju), - kolcanje, - pljučnica (vnetje pljuč), - nezmožnost upreti se impulzu, težnji ali skušnjavi po dejanjih, ki bi lahko škodila vam ali drugim, kot so:
English: Total Daily Dose (mg of base)
Slovenian: Teden Dnevni odmerek (mg baze)
English: In advanced Parkinson's disease, in combination treatment with levodopa, dyskinesia can occur during the initial titration of MIRAPEXIN.
Slovenian: Pri bolnikih z napredovalo Parkinsonovo boleznijo, ki jemljejo zdravilo v kombinaciji z levodopo, se lahko med začetnim stopnjevanjem odmerka zdravila MIRAPEXIN pojavijo diskinezije.
English: When the intake of a dose is missed, MIRAPEXIN prolonged-release tablets should be taken within 12 hours after the regularly scheduled time.
Slovenian: Če bolnik pozabi vzeti odmerek tablet MIRAPEXIN s podaljšanim sproščanjem, ga mora vzeti do 12 ur po predvidenem času jemanja pozabljenega odmerka.
English: Dystonia
Slovenian: Diskinezija
English: Further dose adjustments should be done based on the clinical response and the occurrence of adverse reactions.
Slovenian: Na osnovi kliničnega odziva in pojavnosti neželenih učinov odmerek nadalje prilagodimo.
English: Efficacy was maintained in 87 of 103 patients switched to MIRAPEXIN prolonged-release tablets.
Slovenian: Učinkovitost je ostala po prehodu na MIRAPEXIN tablete s podaljšanim sproščanjem enaka pri 87 od 103 bolnikov.
English: MIRAPEXIN can cause hallucinations (seeing, hearing or feeling things that are not there).
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Zdravilo MIRAPEXIN lahko povzroči halucinacije (pojav, pri katerem vidite, slišite ali čutite nekaj, česar ni).
English: Ascending dose schedule of MIRAPEXIN prolonged-release tablets Week Daily dose (mg of base)
Slovenian: Shema povečevanja odmerka MIRAPEXIN tablet s podaljšanim sproščanjem Teden Dnevni odmerek
English: During the first week, the usual dose is 1 tablet MIRAPEXIN 0.088 mg three times a day (equivalent to 0.264 mg daily):
Slovenian: Običajni odmerek za prvi teden zdravljenja je 1 tableta zdravila MIRAPEXIN po 0,088 mg 3-krat na dan (0,264 mg na dan):
English: MIRAPEXIN prolonged-release tablets were non-inferior to pramipexole immediate release tablets as assessed on the UPDRS Parts II+III score at week 33.
Slovenian: MIRAPEXIN tablete s podaljšanim sproščanjem so bile enakovredne tabletam pramipeksola s takojšnjim sproščanjem, kar je pokazala ocena po lestvici UPDRS, II.
English: Tell your doctor if you have (had) or develop any medical conditions or symptoms, especially any of the following: - Kidney disease - Hallucinations (seeing, hearing or feeling things that are not there).
Slovenian: Obvestite svojega zdravnika, če ste imeli ali se je pri vas razvila katerakoli bolezen, zlasti izmed naslednjih: - Ledvična bolezen.
English: 1 tablet MIRAPEXIN 0.7 mg and 1 tablet MIRAPEXIN 0.35 mg three times a day
Slovenian: 1 tableta zdravila MIRAPEXIN po 0,7 mg in 1 tableta zdravila MIRAPEXIN po 0,35 mg 3-krat na dan
English: MIRAPEXIN 0.26 mg prolonged-release tablets MIRAPEXIN 0.52 mg prolonged-release tablets MIRAPEXIN 1.05 mg prolonged-release tablets MIRAPEXIN 1.57 mg prolonged-release tablets MIRAPEXIN 2.1 mg prolonged-release tablets MIRAPEXIN 2.62 mg prolonged-release tablets MIRAPEXIN 3.15 mg prolonged-release tablets
Slovenian: MIRAPEXIN 0,26 mg tablete s podaljšanim sproščanjem MIRAPEXIN 0,52 mg tablete s podaljšanim sproščanjem MIRAPEXIN 1,05 mg tablete s podaljšanim sproščanjem MIRAPEXIN 1,57 mg tablete s podaljšanim sproščanjem MIRAPEXIN 2,1 mg tablete s podaljšanim sproščanjem MIRAPEXIN 2,62 mg tablete s podaljšanim sproščanjem MIRAPEXIN 3,15 mg tablete s podaljšanim sproščanjem pramipeksol
English: MIRAPEXIN 0.088 mg tablets MIRAPEXIN 0.18 mg tablets MIRAPEXIN 0.35 mg tablets MIRAPEXIN 0.7 mg tablets Pramipexole
Slovenian: MIRAPEXIN 0,088 mg tablete MIRAPEXIN 0,18 mg tablete MIRAPEXIN 0,35 mg tablete MIRAPEXIN 0,7 mg tablete pramipeksol
English: In severe kidney disease, the usual starting dose is just 1 tablet MIRAPEXIN 0.088 mg a day.
Slovenian: Pri hudi ledvični bolezni je običajni odmerek 1 tableta zdravila MIRAPEXIN po 0,088 mg na dan.
English: MIRAPEXIN 0.088 mg tablets MIRAPEXIN 0.18 mg tablets MIRAPEXIN 0.35 mg tablets MIRAPEXIN 0.7 mg tablets
Slovenian: MIRAPEXIN 0,088 mg tablete MIRAPEXIN 0,18 mg tablete MIRAPEXIN 0,35 mg tablete MIRAPEXIN 0,7 mg tablete
English: The maximum plasma concentrations occur at about 6 hours after administration of MIRAPEXIN prolonged-release tablets once daily.
Slovenian: Koncentracija v plazmi je največja približno 6 ur po jemanju MIRAPEXIN tablet s podaljšanim sproščanjem enkrat na dan. Ravnotežno stanje izpostavljenosti se pojavi najpozneje po 5 dneh neprekinjenega jemanja.
English: Thereafter the dose should be reduced by 0.264 mg of base (0.375 mg of salt) per day (see section 4.4).
Slovenian: Nato zmanjšujemo odmerek za 0,264 mg pramipeksola (0,375 mg soli) na dan (glejte poglavje 4.4).
English: During the first week, the usual dose is 1 tablet MIRAPEXIN 0.088 mg once a day (equivalent to 0.088 mg daily):
Slovenian: Običajni odmerek za prvi teden zdravljenja je 1 tableta zdravila MIRAPEXIN po 0,088 mg 1-krat na dan (0,088 mg na dan):
English: Boehringer Ingelheim International GmbH D-55216 Ingelheim am Rhein Germany
Slovenian: Imetnik dovoljenja za promet z zdravilom Boehringer Ingelheim International GmbH D-55216 Ingelheim am Rhein Nemčija
English: A lower maintenance dose of one MIRAPEXIN 0.26 mg prolonged-release tablet a day is also possible.
Slovenian: Možno je tudi zdravljenje z manjšim vzdrževalnim odmerkom, in sicer ena MIRAPEXIN 0,26 mg tableta s podaljšanim sproščanjem na dan.
English: The dose will be increased every 5-7 days as directed by your doctor until your symptoms are controlled (maintenance dose).
Slovenian: Skupni dnevni odmerek (mg) Odmerek boste po zdravnikovih navodilih vsakih 5 do 7 dni povečevali, dokler ne bodo simptomi minili (vzdrževalni odmerek).
English: Ascending dose schedule of MIRAPEXIN Week
Slovenian: Shema povečevanja odmerka zdravila MIRAPEXIN
English: Pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists including MIRAPEXIN (see section 4.4).
Slovenian: Pri bolnikih, ki so se zdravili z dopaminskimi agonisti, tudi zdravilom MIRAPEXIN, se lahko pojavijo patološko hazardiranje, povečan libido, hiperseksualnost, kompulzivno trošenje denarja ali nakupovanje, prenajedanje in kompulzivno uživanje hrane (glejte poglavje 4.4).
English: Initial treatment
Slovenian: Začetek zdravljenja:
English: What MIRAPEXIN contains
Slovenian: Kaj vsebuje zdravilo MIRAPEXIN
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Folding box
Slovenian: PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI Škatla
English: Common: - Urge to behave in an unusual way - Hallucinations (seeing, hearing or feeling things that are not there) - Confusion - Tiredness (fatigue) - Sleeplessness (insomnia) - Excess of fluid, usually in the legs (peripheral oedema) - Headache - Hypotension (low blood pressure) - Abnormal dreams - Constipation - Visual impairment - Vomiting (being sick) - Weight loss including decreased appetite
Slovenian: Pogosti: - siljenje v neobičajno vedenje, - halucinacije (pojav, pri katerem vidite, slišite ali čutite nekaj, česar ni), - zmedenost, - sprememba vzorca spanja, na primer nespečnost ali zaspanost; - utrujenost, - nespečnost (insomnia), - preveč tekočine, običajno v nogah (periferni edem); - glavobol, - hipotenzija (nizek krvni tlak), - nenormalne sanje, - zaprtje, - okvara vida, - bruhanje (slabost), - hujšanje, tudi zmanjšan tek.
English: A lower maintenance dose of three MIRAPEXIN 0.088 mg tablets a day is also possible.
Slovenian: Možno je tudi zdravljenje z manjšim vzdrževalnim odmerkom, in sicer s tremi tabletami zdravila MIRAPEXIN po 0,088 mg na dan.
English: MIRAPEXIN 2.62 mg prolonged-release tablets EU/1/97/051/031-033
Slovenian: MIRAPEXIN 2,62 mg tablete s podaljšanim sproščanjem EU/1/97/051/031-033
English: MIRAPEXIN 0.35 mg tablets EU/1/97/051/011-012
Slovenian: MIRAPEXIN 0,35 mg tablete EU/1/97/051/011-012
English: MIRAPEXIN 0.52 mg prolonged-release tablets EU/1/97/051/016-018
Slovenian: MIRAPEXIN 0,52 mg tablete s podaljšanim sproščanjem EU/1/97/051/016-018
English: Not known: - After stopping or reducing your MIRAPEXIN treatment: Depression, apathy, anxiety, fatigue,
Slovenian: Neznana pogostnost: - Po prenehanju zdravljenja z zdravilom MIRAPEXIN ali zmanjšanju odmerka: pojavijo se lahko depresija, apatija, anksioznost, utrujenost, znojenje ali bolečina (to se imenuje sindrom odtegnitve dopaminskega agonista).
English: MIRAPEXIN has been associated with sleepiness and episodes of suddenly falling asleep, particularly in patients with Parkinson's disease.
Slovenian: Zdravilo MIRAPEXIN so zlasti pri bolnikih s Parkinsonovo boleznijo povezovali z zaspanostjo in epizodami nepremagljivega spanca.
English: The individual dose of pramipexole should be in the range of 0.264 mg of base (0.375 mg of salt) to a maximum of 3.3 mg of base (4.5 mg of salt) per day.
Slovenian: Individualni odmerek pramipeksola naj bo med 0,264 mg pramipeksola (0,375 mg soli) in največ 3,3 mg pramipeksola (4,5 mg soli) na dan.
English: Uncommon: - Urge to behave in an unusual way* - Cardiac failure (heart problems which can cause shortness of breath or ankle swelling)* - Inappropriate antidiuretic hormone secretion* - Dyskinesia (e.g. abnormal, uncontrolled movements of the limbs) - Hyperkinesia (increased movements and inability to keep still)* - Paranoia (e.g. excessive fear for one's own well-being)* - Delusion* - Amnesia (memory disturbance)* - Hallucinations (seeing, hearing or feeling things that are not there) - Confusion - Excessive daytime sleepiness and suddenly falling asleep - Weight increase - Hypotension (low blood pressure) - Excess of fluid, usually in the legs (peripheral oedema) - Allergic reactions (e.g. rash, itching, hypersensitivity) - Fainting - Restlessness - Visual impairment - Weight loss including decreased appetite - Dyspnoea (difficulties to breathe) - Hiccups - Pneumonia (infection of the lungs)* - Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
Slovenian: Občasni: - siljenje v neobičajno vedenje*, - srčno popuščanje (srčne motnje, ki lahko povzročijo težave z dihanjem in otekanje gležnjev)*, - neustrezno izločanje antidiuretičnega hormona*, - diskinezija (npr. nenormalni, nenadzorovani gibi udov), - hiperkinezija (čezmerni gibi in nezmožnost mirovanja)*, - paranoja (npr. prevelik strah za lastno dobrobit)*, - blodnje*, - amnezija (moten spomin)*, - halucinacije (pojav, pri katerem vidite, slišite ali čutite nekaj, česar ni), - zmedenost, - prevelika zaspanost podnevi in nenaden nepremagljiv spanec, - zvečanje telesne mase, - hipotenzija (nizek krvni tlak), - preveč tekočine, običajno v nogah (periferni edem), - alergijske reakcije (npr. izpuščaj, srbenje, preobčutljivost), - omedlevica, - nemir, - okvara vida, - hujšanje, tudi zmanjšan tek;
English: MIRAPEXIN 0.26 mg prolonged-release tablets Each prolonged-release tablet contains 0.375 mg pramipexole dihydrochloride monohydrate equivalent to 0.26 mg pramipexole.
Slovenian: MIRAPEXIN 0,26 mg tablete s podaljšanim sproščanjem Ena tableta s podaljšanim sproščanjem vsebuje 0,26 mg pramipeksola v obliki 0,375 mg pramipeksolijevega diklorida monohidrata.
English: You should have regular eye examinations during treatment with MIRAPEXIN.
Slovenian: - Motnje vida: Med zdravljenjem z zdravilom MIRAPEXIN morate redno hoditi na preglede oči.
English: This will be increased every 4-7 days as directed by your doctor until your symptoms are controlled (maintenance dose).
Slovenian: Skupni dnevni odmerek (mg) Odmerek boste po zdravnikovih navodilih vsake 4 do 7 dni povečevali, dokler simptomi ne bodo minili (vzdrževalni odmerek).
English: MIRAPEXIN 0.088 mg tablets EU/1/97/051/001-002
Slovenian: MIRAPEXIN 0,088 mg tablete EU/1/97/051/001-002
English: If you forget for more than 12 hours, simply take the next single dose at the usual time.
Slovenian: Če je od takrat, ko bi morali vzeti tableto, preteklo več kot 12 ur, vzemite nasledni odmerek kot običajno.
English: MIRAPEXIN 0.7 mg tablets EU/1/97/051/005-006
Slovenian: MIRAPEXIN 0,7 mg tablete EU/1/97/051/005-006
English: If a further dose increase is necessary the daily dose should be increased by 0.54 mg of base (0.75 mg of salt) at weekly intervals up to a maximum dose of 3.3 mg of base (4.5 mg of salt) per day.
Slovenian: Če je potrebno nadaljnje večanje odmerka, lahko dnevni odmerek v tedenskih intervalih povečujemo za 0,54 mg pramipeksola (0,75 mg soli) do največjega odmerka 3,3 mg pramipeksola (4,5 mg soli) na dan.
English: - Binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger)* - Delirium (decreased awareness, confusion, loss of reality)
Slovenian: - spremenjeno ali povečano spolno zanimanje in vedenje, ki vam ali drugim povzroča znatno zaskrbljenost, na primer povečan libido; - čezmerno nakupovanje ali trošenje denarja, ki ju ne morete nadzorovati; - prenajedanje (uživanje velikih količin hrane v kratkem obdobju) ali kompulzivno uživanje hrane (uživanje večjih količin hrane od normalnih in več, kot je potrebno za potešitev lakote)*, - delirij (zmanjšano zavedanje, zmedenost, izguba občutka za resničnost).
English: Doses should be increased gradually from a starting dose of 0.26 mg of base (0.375 mg of salt) per day and then increased every 5-7 days.
Slovenian: Zdravljenje pričnemo z začetnim odmerkom 0,26 mg pramipeksola (0,375 mg soli) na dan, ki ga postopno povečujemo vsakih 5-7 dni.
English: Doses should be increased gradually from a starting dose of 0.264 mg of base (0.375 mg of salt) per day and then increased every 5-7 days.
Slovenian: Zdravljenje pričnemo z začetnim odmerkom 0,264 mg pramipeksola (0,375 mg soli) na dan, ki ga postopno povečujemo vsakih 5-7 dni.
English: MIRAPEXIN 0.088 mg tablets
Slovenian: MIRAPEXIN 0,088 mg tablete
English: Dopamine agonist withdrawal syndrome including apathy, anxiety, depression, fatigue, sweating and pain.
Slovenian: Splošne težave in spremembe na mestu aplikacije utrujenost periferni edem sindrom odtegnitve dopaminskega agonista, vključno z apatijo, anksioznostjo, depresijo, utrujenostjo, znojenjem in bolečino.
English: MIRAPEXIN 0.18 mg tablets EU/1/97/051/003-004
Slovenian: MIRAPEXIN 0,18 mg tablete EU/1/97/051/003-004
English: MIRAPEXIN 0.35 mg tablets
Slovenian: MIRAPEXIN 0,35 mg tablete
English: It can be used alone or in combination with levodopa (another medicine for Parkinson's disease).
Slovenian: Zdravilo MIRAPEXIN uporabljamo za zdravljenje simptomov primarne Parkinsonove bolezni pri odraslih; lahko ga uporabljamo samostojno ali v kombinaciji z levodopo (drugo zdravilo za Parkinsonovo bolezen).
English: 2 tablets MIRAPEXIN 0.088 mg three times a day
Slovenian: 2 tableti zdravila MIRAPEXIN po 0,088 mg 3-krat na dan
English: INFORMATION IN BRAILLE MIRAPEXIN 0.088 mg
Slovenian: PODATKI V BRAILLOVI PISAVI MIRAPEXIN 0,088 mg
English: The active substance is pramipexole.
Slovenian: Učinkovina je pramipeksol.
English: During dose escalation in pivotal studies, efficacy was observed starting at a daily dose of 1.1 mg of base (1.5 mg of salt).
Slovenian: Pri stopnjevanju odmerka so v ključnih študijah opazili učinkovitost pri dnevnih odmerkih 1,1 mg pramipeksola (1,5 mg soli) in več.
English: MIRAPEXIN 2.62 mg prolonged-release tablets
Slovenian: MIRAPEXIN 2,62 mg tablete s podaljšanim sproščanjem pramipeksol
English: INFORMATION IN BRAILLE MIRAPEXIN 2.62 mg prolonged-release tablets
Slovenian: PODATKI V BRAILLOVI PISAVI MIRAPEXIN 2,62 mg tablete s podaljšanim sproščanjem
English: 1 tablet MIRAPEXIN 0.088 mg three times a day
Slovenian: 1 tableta zdravila MIRAPEXIN po 0,088 mg 3-krat na dan
English: for example, an increased sexual drive.
Slovenian: - Povečanje simptomov.
English: MIRAPEXIN 0.7 mg tablets
Slovenian: MIRAPEXIN 0,7 mg tablete
English: MIRAPEXIN 1.05 mg prolonged-release tablets
Slovenian: MIRAPEXIN 1,05 mg tablete s podaljšanim sproščanjem pramipeksol
English: MIRAPEXIN 0.52 mg prolonged-release tablets
Slovenian: MIRAPEXIN 0,52 mg tablete s podaljšanim sproščanjem pramipeksol
English: MIRAPEXIN 0.26 mg prolonged-release tablets
Slovenian: MIRAPEXIN 0,26 mg tablete s podaljšanim sproščanjem pramipeksol